908 Devices (MASS) EBT Margin Growth (1y) (2021 - 2026)
908 Devices (MASS) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 165.00 |
| 10 | 908 Devices | 386.71 Mn | 285.18 Mn | 8.34 Mn | 2,415.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,415.00 |
| Mar 31, 2026 | -28.00 |
| Dec 31, 2025 | 13,595.00 |
| Sep 30, 2025 | 5,662.00 |
| Jun 30, 2025 | -3,241.00 |
| Mar 31, 2025 | 3,713.00 |
| Dec 31, 2024 | -5,994.00 |
| Sep 30, 2024 | -11,266.00 |
| Jun 30, 2024 | 1,179.00 |
| Mar 31, 2024 | -1,594.00 |
| Dec 31, 2023 | 3,231.00 |
| Sep 30, 2023 | -1,060.00 |
| Jun 30, 2023 | -494.00 |
| Mar 31, 2023 | -353.00 |
| Dec 31, 2022 | -5,293.00 |
| Sep 30, 2022 | 1,185.00 |
| Jun 30, 2022 | 2,911.00 |
| Mar 31, 2022 | -416.00 |
| Dec 31, 2021 | 43,710.00 |
| Sep 30, 2021 | -977.00 |